Los Angeles Capital Management
ACHV icon

Los Angeles Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Los Angeles Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-8
Closed -$200K – 1190
2014
Q1 		$200K Buy
+8
New +$197K ﹤0.01% 1189

Other funds holding ACHV

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Los Angeles Capital Management's ACHV Position: Q2 2014 in Review

Los Angeles Capital Management sold out of Achieve Life Sciences (ACHV) in Q2 2014, closing a stake of 8 shares — an estimated $200K sold.

Los Angeles Capital Management first reported a position in ACHV in Q1 2014 and held it in 1 quarter. The position peaked at $200K in Q1 2014. 63 funds tracked by Wall St. Rank hold ACHV as of Q2 2014.

  • Los Angeles Capital Management reported no remaining Achieve Life Sciences position as of Q2 2014 after selling out during the quarter.
  • Los Angeles Capital Management sold 8 Achieve Life Sciences shares in Q2 2014, an estimated $200K.
  • Los Angeles Capital Management first reported a position in Achieve Life Sciences in Q1 2014 and held it in 1 quarter.
  • Los Angeles Capital Management's Achieve Life Sciences position peaked at $200K in Q1 2014.
  • 63 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2014.

Based on Los Angeles Capital Management's 13F filing for Q2 2014, filed 12 Aug 2014.